1. Low-dose repeated exposure to chemical surfactant impairs corneal epithelium: When personal cleaning products entering the eye
   Jie Wu et al, 2021, Experimental Eye Research CrossRef
2. Clinical Significance of Circulating Tumor Cell Induced Epithelial-Mesenchymal Transition in Patients with Metastatic Colorectal Cancer by Single-Cell RNA-Sequencing
   Masahiro Kozuka et al, 2021, Cancers CrossRef
3. Does rarity mean imparity? Biological characteristics of osteosarcoma cells originating from the spine
   Zhenhua Zhou et al, 2017, Journal of Cancer Research and Clinical Oncology CrossRef
4. Comprehensive pan-carcinoma analysis of ITGB1 distortion and its potential clinical significance for cancer immunity
   Yuchang Fei et al, 2024, Discover Oncology CrossRef
5. Psoralidin inhibits osteosarcoma growth and metastasis by downregulating ITGB1 expression via the FAK and PI3K/Akt signaling pathways
   Shengwen Cheng et al, 2023, Chinese Medicine CrossRef
6. 2-Methoxy-1,4-naphthoquinone (MNQ) regulates cancer key genes of MAPK, PI3K, and NF-κB pathways in Raji cells
   Teck Yew Wong et al, 2022, Genomics & Informatics CrossRef
7. ITGB1 Drives Hepatocellular Carcinoma Progression by Modulating Cell Cycle Process Through PXN/YWHAZ/AKT Pathways
   Jinghe Xie et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
8. A SARS-CoV-2 –human metalloproteome interaction map
   Christos T. Chasapis et al, 2021, Journal of Inorganic Biochemistry CrossRef
9. Multipotent mesenchymal stromal cells promote tumor growth in distinct colorectal cancer cells by a β1‐integrin‐dependent mechanism
   Miriam Widder et al, 2016, International Journal of Cancer CrossRef
10. Midkine is neuroprotective and influences glial reactivity and the formation of Müller glia‐derived progenitor cells in chick and mouse retinas
    Warren A. Campbell et al, 2021, Glia CrossRef
11. Proteomic Level Changes on Treatment in MCF-7/DDP Breast Cancer Drug- Resistant Cells
    Gongshen Jin et al, 2020, Anti-Cancer Agents in Medicinal Chemistry CrossRef
12. Hypoxia-inducible ERO1α promotes cancer progression through modulation of integrin-β1 modification and signalling in HCT116 colorectal cancer cells
    Norio Takei et al, 2017, Scientific Reports CrossRef
13. Inhibition of integrin β1 decreases the malignancy of ovarian cancer cells and potentiates anticancer therapy via the FAK/STAT1 signaling pathway
    LEI ZHANG et al, 2015, Molecular Medicine Reports CrossRef
14. NF-κB signaling and integrin-β1 inhibition attenuates osteosarcoma metastasis via increased cell apoptosis
    Rui Li et al, 2019, International Journal of Biological Macromolecules CrossRef
15. Integrinβ-1 in disorders and cancers: molecular mechanisms and therapeutic targets
    Chen Su et al, 2024, Cell Communication and Signaling CrossRef
16. Integrin-mediated cancer progression as a specific target in clinical therapy
    Jian-Rui Chen et al, 2022, Biomedicine & Pharmacotherapy CrossRef
17. Extracellular matrix gene expression profiling using microfluidics for colorectal carcinoma stratification
    Christopher J. Hayes et al, 2016, Biomicrofluidics CrossRef
18. Anoikis and the Human Gut Epithelium in Health and Disease
    Marco Beauséjour et al, 2021, Anoikis CrossRef
19. Pro-apoptotic effects of pycnogenol on HT1080 human fibrosarcoma cells
    KAMRAN HARATI et al, 2015, International Journal of Oncology CrossRef
20. Adoptive Immunotherapy for Small Cell Lung Cancer by Expanded Activated Autologous Lymphocytes: a Retrospective Clinical Analysis
    Guo-Qing Zhang et al, 2015, Asian Pacific Journal of Cancer Prevention CrossRef
21. Integrin subunit β1 and laminin γ1 chain expression: a potential prognostic biomarker in cervical cancer
    Ana E Zacapala-Gómez et al, 2020, Biomarkers in Medicine CrossRef
22. Acid ceramidase inhibition sensitizes human colon cancer cells to oxaliplatin through downregulation of transglutaminase 2 and β1 integrin/FAK−mediated signalling
    Marko Klobučar et al, 2018, Biochemical and Biophysical Research Communications CrossRef